At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Apr 10, 2026 at 16:45 ET
Two corporate insiders at Kymera Therapeutics sold shares in the past week, including Director Booth Bruce selling 4,159 shares for $374,185 and Chief Business Officer Noah Goodman selling 2,000 shares for $174,700. The total open-market sales amount to $549,000, representing 0.0075% of the company's $7.3B market cap. Most transactions were non-cash derivative exercises with no economic impact.
- Director Booth Bruce sold 4,159 shares for $374,185 on 2026-04-14 and also exercised 10,518 derivative shares (non-cash) across multiple transactions.
- Chief Business Officer Noah Goodman sold 2,000 shares for $174,700 on 2026-04-10.
- Total open-market sales in the cluster: $549,000.
- Total value represents 0.0075% of Kymera's $7.3B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access